Contineum Therapeutics (CTNM) Preferred Shares Issued (2023)
Contineum Therapeutics (CTNM) recorded quarterly Preferred Shares Issued of $10.2 million in Q3 2023, down 63.29% quarter-over-quarter from $27.9 million in Q2 2023.
Contineum Therapeutics (CTNM) Preferred Shares Issued (2023) Analysis & Trends
Contineum Therapeutics' Preferred Shares Issued history runs 1 years deep, the most recent figure standing at $10.2 million for Q3 2023.
- In Q3 2023, Preferred Shares Issued changed N/A year-over-year to $10.2 million; the TTM figure through Dec 2024 stood at $10.2 million (changed N/A YoY), while the FY2023 annual figure was $60.1 million, changed N/A from the prior year.
- Preferred Shares Issued was $10.2 million for Q3 2023 at Contineum Therapeutics, down from $27.9 million in the prior quarter.
- In the past five years, Preferred Shares Issued ranged from a high of $27.9 million in Q2 2023 to a low of $10.2 million in Q3 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | - |
| 10 | Contineum Therapeutics | 423.05 Mn | 423.05 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | 10.24 Mn |
| Sep 30, 2023 | 10.24 Mn |
| Jun 30, 2023 | 27.90 Mn |
| Jun 30, 2023 | 27.90 Mn |